Deliver Your News to the World

CybeRelease: (OTC BB: BSLM) Completes Initial Closing of Private Placement


WEBWIRE

(CybeRelease, June 23, 2006) - Lake Harmony - Bio-Solutions Manufacturing, Inc. (OTCBB: BSLM - News; Frankfurt: B2T.F - News) announced today that it has completed the initial closing of $1,000,000 of a $2,250,000 private placement with European institutional investors. In the placement, Bio-Solutions issued 2,500,000 units, each unit consisting of one share of common stock and a warrant to purchase one share of common stock at $0.80 per share, at a purchase price of $0.40 per unit. The company intends to keep the placement open for a reasonable period of time to accept additional subscriptions for the remaining $1,250,000 worth of units being offered. Bio Solutions retained T&T Vermogensverwaltungs AG of Switzerland as its investment banker for the transaction.

“T & T has financed many companies in the US and Europe and is looking forward to working with Bio-Solutions Manufacturing, a revolutionary bioremediation and bio-diesel company,” says Mr. Ivano Anglestri, T & T’s President.

“We are very pleased to have T & T as a business partner and we are looking forward to the opportunities this venture will bring,” says Mr. David Bennett, President and CEO of Bio-Solutions Manufacturing. “This funding gives us the ability to develop and market our biodiesel and environmental products.”

For a Free Newsletter and more, go to http://www.OTCReporter.com

To read the complete release, go to http://www.CybeRelease.com/bslm62306.htm

CybeRelease Gainers are Penwest Pharmaceuticals Co. (Nasdaq: PPCO), Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), Arch Capital Group Ltd. (Nasdaq: ACGL), Internet Initiative Japan, Inc. (Nasdaq: IIJI), Sepracor Inc. (Nasdaq: SEPR), GMX Resources, Inc. (Nasdaq: GMXR) and Pacific Ethanol, Inc. (Nasdaq: PEIX).

CybeRelease Decliners are Neurocrine Biosciences, Inc. (NasdaqNM:NBIX - News), Sunterra Corporation New (Nasdaq: SNRR), DOV Pharmaceutical, Inc. (Nasdaq: DOVP), Pixelplus Co., Ltd. (Nasdaq: PXPL), Anglo American plc (Nasdaq: AAUK), Xilinx, Inc. (Nasdaq: XLNX), Inergy, L.P. (Nasdaq: NRGY) and QUALCOMM Incorporated (Nasdaq: QCOM).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $595.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.



WebWireID15678





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.